Louise Charest

740 total citations
15 papers, 393 citations indexed

About

Louise Charest is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Louise Charest has authored 15 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Infectious Diseases and 4 papers in Surgery. Recurrent topics in Louise Charest's work include HIV/AIDS Research and Interventions (7 papers), HIV, Drug Use, Sexual Risk (6 papers) and Colorectal and Anal Carcinomas (3 papers). Louise Charest is often cited by papers focused on HIV/AIDS Research and Interventions (7 papers), HIV, Drug Use, Sexual Risk (6 papers) and Colorectal and Anal Carcinomas (3 papers). Louise Charest collaborates with scholars based in Canada, Switzerland and France. Louise Charest's co-authors include Pierre Duquette, Marc Girard, J Pleines, Caroline Masse, Réjean Thomas, Danièle Longpré, Zoë R. Greenwald, Vinh‐Kim Nguyen, Helen Trottier and Daniel Murphy and has published in prestigious journals such as PLoS ONE, Neurology and AIDS.

In The Last Decade

Louise Charest

15 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Louise Charest Canada	8	178	171	94	85	60	15	393
N. H. Brockmeyer Germany	14	133 0.7×	186 1.1×	83 0.9×	28 0.3×	52 0.9×	36	511
Jennifer E. Gerber United States	10	76 0.4×	127 0.7×	104 1.1×	55 0.6×	46 0.8×	19	560
Michael Guger Austria	12	103 0.6×	57 0.3×	207 2.2×	23 0.3×	54 0.9×	38	425
Jaclyn Hern United States	12	95 0.5×	137 0.8×	87 0.9×	27 0.3×	78 1.3×	18	383
Shunying Zhao China	16	165 0.9×	235 1.4×	11 0.1×	16 0.2×	99 1.6×	52	656
Jean Cantey-Kiser United States	9	92 0.5×	30 0.2×	20 0.2×	16 0.2×	43 0.7×	11	578
Minghua Zhuang China	17	470 2.6×	331 1.9×	6 0.1×	87 1.0×	27 0.5×	32	750
Marcello Aragona Italy	12	29 0.2×	143 0.8×	19 0.2×	20 0.2×	20 0.3×	24	546
Caiping Guo China	13	172 1.0×	106 0.6×	13 0.1×	7 0.1×	30 0.5×	43	449
Saúl Reyes Colombia	10	167 0.9×	31 0.2×	300 3.2×	8 0.1×	53 0.9×	38	496

Countries citing papers authored by Louise Charest

Since Specialization

Citations

This map shows the geographic impact of Louise Charest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louise Charest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louise Charest more than expected).

Fields of papers citing papers by Louise Charest

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louise Charest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louise Charest. The network helps show where Louise Charest may publish in the future.

Co-authorship network of co-authors of Louise Charest

This figure shows the co-authorship network connecting the top 25 collaborators of Louise Charest. A scholar is included among the top collaborators of Louise Charest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louise Charest. Louise Charest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Williamson, Tyler, Marie‐Hélène Mayrand, Ann N. Burchell, et al.. (2022). Identifying risk factors for prevalent anal human papillomavirus type 16 infection in women living with HIV. PLoS ONE. 17(5). e0268521–e0268521. 2 indexed citations

Panagiotoglou, Dimitra, Zoë R. Greenwald, Louise Charest, et al.. (2022). Chemsex and incidence of sexually transmitted infections among Canadian pre-exposure prophylaxis (PrEP) users in the l’Actuel PrEP Cohort (2013–2020). Sexually Transmitted Infections. 98(8). 549–556. 25 indexed citations

Giguère, Katia, Olivier Clément, Louise Charest, et al.. (2021). Characteristics of new HIV diagnoses over 1995–2019: A clinic-based study in Montréal, Canada. PLoS ONE. 16(10). e0258383–e0258383. 3 indexed citations

Greenwald, Zoë R., et al.. (2020). Pre-exposure Prophylaxis Uptake Among Men Who Have Sex With Men Who Used nPEP: A Longitudinal Analysis of Attendees at a Large Sexual Health Clinic in Montréal (Canada). JAIDS Journal of Acquired Immune Deficiency Syndromes. 85(4). 408–415. 8 indexed citations

Williamson, Tyler, Marie‐Hélène Mayrand, Ann N. Burchell, et al.. (2020). Acceptability of Anal Cancer Screening Tests for Women Living with HIV in the EVVA Study. Current Oncology. 27(1). 19–26. 14 indexed citations

Greenwald, Zoë R., et al.. (2018). High seroconversion rates following PrEP discontinuance in a Montreal clinic. Journal of Virus Eradication. 4. 12–12. 7 indexed citations

Pokomandy, Alexandra de, Marie‐Hélène Mayrand, Louise Charest, et al.. (2018). Two-years persistence of anal high-risk HPV infections in women living with HIV, results from the EVVA study. Papillomavirus Research. 5. S12–S12. 1 indexed citations

Charest, Louise, Judith Fafard, & Zoë R. Greenwald. (2018). Asymptomatic urethral lymphogranuloma venereum: a case report. International Journal of STD & AIDS. 29(8). 828–830. 3 indexed citations

Nguyen, Vinh‐Kim, Zoë R. Greenwald, Helen Trottier, et al.. (2017). Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV. AIDS. 32(4). 523–530. 108 indexed citations

10.

Thomas, Richard, et al.. (2016). P-01-066 PrEP in Montreal: Good Adherence, No Seroconversion and No Evidence of Risk Compensation. The Journal of Sexual Medicine. 13(Supplement_2). S165–S165. 3 indexed citations

11.

Thomas, Réjean, Chrissi Galanakis, Sylvie Vézina, et al.. (2015). Adherence to Post-Exposure Prophylaxis (PEP) and Incidence of HIV Seroconversion in a Major North American Cohort. PLoS ONE. 10(11). e0142534–e0142534. 47 indexed citations

12.

Trottier, Benoît, Nimâ Machouf, Sylvie Vézina, et al.. (2014). Tolerability is more important than simplicity for treatment durability. Journal of the International AIDS Society. 17(4S3). 19765–19765. 6 indexed citations

13.

Duquette, Pierre, et al.. (1992). The Increased Susceptibility of Women to Multiple Sclerosis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 19(4). 466–471. 148 indexed citations

14.

Charest, Louise, et al.. (1989). Growth Hormone Rebound After Cessation of SMS 201-995 Treatment in Acromegaly. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 16(4). 442–445. 6 indexed citations

15.

Duquette, Pierre & Louise Charest. (1986). Cerebrospinal fluid findings in healthy siblings of multiple sclerosis patients. Neurology. 36(5). 727–727. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact